Revvity | Ativo Circulante



Current Assets Alterar Data
Adcock Ingram Holdings ZAR 5.12B 234.71M 2024-12
Agilent USD 4.21B 101M 2025-04
Align Technology USD 2.45B 46.03M 2025-06
Bio Techne USD 608.3M 18.94M 2025-06
Bio-Rad Laboratories USD 2.81B 225.5M 2025-06
Bruker USD 2.16B 51.2M 2025-06
Celltrion KRW 5.46T 122.95B 2025-03
Charles River Laboratories USD 1.47B 36.5M 2025-06
Cspc Pharmaceutical CNY 21.89B 4.58B 2024-12
Danaher USD 11B 1.47B 2025-06
Dentsply International USD 1.97B 12M 2025-06
Dianthus Therapeutics USD 280.9M 6.58M 2024-12
Divis Laboratories Ltd 100.81B 7.4B 2025-03
Edwards Lifesciences USD 6.21B 72.7M 2025-03
Exact Sciences USD 1.51B 137.52M 2025-06
Hologic USD 3.42B 212.7M 2025-06
Illumina USD 2.64B 32M 2025-06
Intuitive Surgical USD 12.47B 592.4M 2025-06
IQVIA Holdings USD 6.35B 434M 2025-06
Kangmei Pharma CNY 6.89B 6.07M 2025-03
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 489.61M 51.17M 2024-12
Laboratory Of America USD 4.09B 297.5M 2025-06
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.41M 7.26M 2024-12
Mettler Toledo International USD 1.24B 79.67M 2025-06
Myriad Genetics USD 287.2M 10.8M 2025-03
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Pharma Mar EUR 249.4M 13.39M 2025-06
Qiagen NV USD 1.82B 76.12M 2025-06
Quest Diagnostics USD 2.2B 123M 2025-06
Quidel USD 1.28B 23.3M 2025-06
Repligen USD 1.03B 33.58M 2025-03
Revvity USD 2.24B 81.76M 2025-06
Sartorius EUR 2.17B 7.5M 2025-06
Sino Biopharmaceutical CNY 24.69B 536.66M 2024-12
Thermo Fisher Scientific USD 24.58B 1.21B 2025-06
Tilray USD 707.34M 18.54M 2024-11
Waters USD 1.78B 42.24M 2025-06
Zz Pientze Pharmaceu 12.18B 849.77M 2025-03


Revvity Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.